You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
SUSPECTED BOTULISM STATUS POST ANTITOXIN THERAPY: A CASE REPORT
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-046
- By: CHOU, Kuang-Yu (E-Da Hospital, Pharmacy, China Taiwan)
- Co-author(s): Kuang-Yu Chou: Pharmacy Department, E-Da Hospital, Kaohsiung City, China Taiwan
Yi-Ping Hsiang: Pharmacy Department, E-Da Hospital, Kaohsiung City, China Taiwan - Abstract:
Background
Botulinum toxin, produced by Clostridium botulinum, weakens or paralyzes skeletal through the inhibition of neurotransmission between peripheral nerve endings and muscle fibers. Botulinum toxins are represented by at least 7 serotypes (A, B, C, D, E, F, and G).Botulism is an illness caused by botulinum toxin. The manifestations include
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026